The global measles, mumps and rubella (MMR) vaccines market is expected to grow at a CAGR of 5.5% during the forecast period from 2021 to 2030. The growth in this market can be attributed to the increasing number of outbreaks of these diseases across the globe. The MMR vaccine is administered as a single dose or as two doses depending on the age group and it protects against measles, mumps and rubella. It is recommended for children between 12 months and 15 years old, pregnant women who are not immune to these diseases, people with weakened immune systems due to HIV/AIDS or cancer treatment, healthcare workers who are exposed to these diseases through their work environment and travelers going abroad.
The monovalent vaccine segment accounted for more than half of the total revenue share in 2018 owing to its higher demand in developing countries such as India where there is a high prevalence rate of measles disease among children below five years old.
- The MMR vaccine is a combination of three vaccines that protect against measles, mumps and rubella.
- The MMR vaccine is the most effective way to prevent these diseases in children and adults.
- The CDC recommends two doses of the MMR vaccine for children, starting with the first dose at 12-15 months old and the second dose at 4-6 years old (or as soon as possible).
- In recent years, there has been an increase in measles outbreaks in Europe due to low vaccination rates among young people who are not vaccinated or undervaccinated because they missed one or more doses of the MMR vaccine.
- There have also been outbreaks in other parts of the world including Africa, Asia, South America and North America.
Industry Growth Insights published a new data on “Measles, Mumps and Rubella (MMR) Vaccines Market”. The research report is titled “Measles, Mumps and Rubella (MMR) Vaccines Market research by Types (Monovalent Vaccine, Polyvalent Vaccine), By Applications (Immune Center, Vaccine Development Agencies and Organizations, Hospital, Laboratory, Biotechnology and Biopharmaceutical Companies), By Players/Companies Medlmmune, Johnson & Johnson, Merck, Sanofi, Serum, Bavarian Nordic, Astellas Pharma, Emergent BioSolutions, GlaxoSmithKline, Pfizer, CSL”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Measles, Mumps and Rubella (MMR) Vaccines Market Research Report
By Type
Monovalent Vaccine, Polyvalent Vaccine
By Application
Immune Center, Vaccine Development Agencies and Organizations, Hospital, Laboratory, Biotechnology and Biopharmaceutical Companies
By Companies
Medlmmune, Johnson & Johnson, Merck, Sanofi, Serum, Bavarian Nordic, Astellas Pharma, Emergent BioSolutions, GlaxoSmithKline, Pfizer, CSL
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
 Vaccines Industry Outlook.svg)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Report Segments:
The global Measles, Mumps and Rubella (MMR) Vaccines market is segmented on the basis of:
Types
Monovalent Vaccine, Polyvalent Vaccine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Immune Center, Vaccine Development Agencies and Organizations, Hospital, Laboratory, Biotechnology and Biopharmaceutical Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medlmmune
- Johnson & Johnson
- Merck
- Sanofi
- Serum
- Bavarian Nordic
- Astellas Pharma
- Emergent BioSolutions
- GlaxoSmithKline
- Pfizer
- CSL
 Vaccines Market Overview.svg)
Highlights of The Measles, Mumps and Rubella (MMR) Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monovalent Vaccine
- Polyvalent Vaccine
- By Application:
- Immune Center
- Vaccine Development Agencies and Organizations
- Hospital
- Laboratory
- Biotechnology and Biopharmaceutical Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Measles, Mumps and Rubella (MMR) Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Vaccines Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
MMR vaccines are a series of shots that help protect against measles, mumps and rubella (MMR). These diseases are highly contagious and can cause serious health problems, including pneumonia, encephalitis (a brain infection), and even death. MMR vaccines work best when given in combination with other childhood vaccinations.
Some of the key players operating in the measles, mumps and rubella (mmr) vaccines market are Medlmmune, Johnson & Johnson, Merck, Sanofi, Serum, Bavarian Nordic, Astellas Pharma, Emergent BioSolutions, GlaxoSmithKline, Pfizer, CSL.
The measles, mumps and rubella (mmr) vaccines market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Measles, Mumps and Rubella (MMR) Vaccines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Measles, Mumps and Rubella (MMR) Vaccines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Measles, Mumps and Rubella (MMR) Vaccines Market - Supply Chain
4.5. Global Measles, Mumps and Rubella (MMR) Vaccines Market Forecast
4.5.1. Measles, Mumps and Rubella (MMR) Vaccines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Measles, Mumps and Rubella (MMR) Vaccines Market Size (000 Units) and Y-o-Y Growth
4.5.3. Measles, Mumps and Rubella (MMR) Vaccines Market Absolute $ Opportunity
5. Global Measles, Mumps and Rubella (MMR) Vaccines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Type
5.3.1. Monovalent Vaccine
5.3.2. Polyvalent Vaccine
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Measles, Mumps and Rubella (MMR) Vaccines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Application
6.3.1. Immune Center
6.3.2. Vaccine Development Agencies and Organizations
6.3.3. Hospital
6.3.4. Laboratory
6.3.5. Biotechnology and Biopharmaceutical Companies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Measles, Mumps and Rubella (MMR) Vaccines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Measles, Mumps and Rubella (MMR) Vaccines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Measles, Mumps and Rubella (MMR) Vaccines Demand Share Forecast, 2019-2026
9. North America Measles, Mumps and Rubella (MMR) Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Application
9.4.1. Immune Center
9.4.2. Vaccine Development Agencies and Organizations
9.4.3. Hospital
9.4.4. Laboratory
9.4.5. Biotechnology and Biopharmaceutical Companies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Type
9.7.1. Monovalent Vaccine
9.7.2. Polyvalent Vaccine
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Measles, Mumps and Rubella (MMR) Vaccines Demand Share Forecast, 2019-2026
10. Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Application
10.4.1. Immune Center
10.4.2. Vaccine Development Agencies and Organizations
10.4.3. Hospital
10.4.4. Laboratory
10.4.5. Biotechnology and Biopharmaceutical Companies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Type
10.7.1. Monovalent Vaccine
10.7.2. Polyvalent Vaccine
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Measles, Mumps and Rubella (MMR) Vaccines Demand Share Forecast, 2019-2026
11. Europe Measles, Mumps and Rubella (MMR) Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Application
11.4.1. Immune Center
11.4.2. Vaccine Development Agencies and Organizations
11.4.3. Hospital
11.4.4. Laboratory
11.4.5. Biotechnology and Biopharmaceutical Companies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Groth Projections by Application
11.7. Europe Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Type
11.7.1. Monovalent Vaccine
11.7.2. Polyvalent Vaccine
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Measles, Mumps and Rubella (MMR) Vaccines Demand Share, 2019-2026
12. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Application
12.4.1. Immune Center
12.4.2. Vaccine Development Agencies and Organizations
12.4.3. Hospital
12.4.4. Laboratory
12.4.5. Biotechnology and Biopharmaceutical Companies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Type
12.7.1. Monovalent Vaccine
12.7.2. Polyvalent Vaccine
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Demand Share, 2019-2026
13. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Application
13.4.1. Immune Center
13.4.2. Vaccine Development Agencies and Organizations
13.4.3. Hospital
13.4.4. Laboratory
13.4.5. Biotechnology and Biopharmaceutical Companies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Market Size and Volume Forecast by Type
13.7.1. Monovalent Vaccine
13.7.2. Polyvalent Vaccine
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Measles, Mumps and Rubella (MMR) Vaccines Market: Market Share Analysis
14.2. Measles, Mumps and Rubella (MMR) Vaccines Distributors and Customers
14.3. Measles, Mumps and Rubella (MMR) Vaccines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medlmmune
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson & Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sanofi
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Serum
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bavarian Nordic
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Astellas Pharma
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Emergent BioSolutions
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. GlaxoSmithKline
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Pfizer
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. CSL
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
